Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease

By Crane Andrew T.   Rossignol Julien   Dunbar Gary L.  

Brain Sciences, Vol. 4, Iss. 1, 2014-03 ,pp. : 202-219

MDPI

Access to resources Recommend Favorite

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

By Valdeolivas Sara   Sagredo Onintza   Delgado Mercedes   Pozo Miguel A.   Fernández-Ruiz Javier  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite

Deep Brain Stimulation in Huntington’s Disease—Preliminary Evidence on Pathophysiology, Efficacy and Safety

By Wojtecki Lars   Groiss Stefan Jun   Hartmann Christian Johannes   Elben Saskia   Omlor Sonja   Schnitzler Alfons   Vesper Jan  

Brain Sciences, Vol. 6, Iss. 3, 2016-08 ,pp. : 38-38

MDPI

Access to resources Recommend Favorite

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease

By Kolli Nivya   Lu Ming   Maiti Panchanan   Rossignol Julien   Dunbar Gary L.  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 754-754

MDPI

Access to resources Recommend Favorite